Skip to main content
Premium Trial:

Request an Annual Quote

HHS Seeks to Fund Bioassays for Radiological Dosage Testing

NEW YORK (GenomeWeb News) — A branch of the US Department of Health and Human Services responsible for developing responses to bioweapons is seeking applicants to develop bioassay technologies that could be used in the event of a nuclear detonation or of a radiological device, or 'dirty bomb,' to assess the radiation doses to which people have been exposed.

The Biomedical Advanced Research and Development Authority (BARDA) program will fund advanced development of biomarkers, bioassays, biological dosage measurement tools that could be used to create a rapid point-of-care diagnostic tool for post-nuclear or radiological events.

Those seeking to apply for the support should request funds to advance "a promising diagnostic product" and should propose "a well-defined product development path that must include completion and validation, and potentially approval/clearance, of a prototype instrument or bioassay prior to or within five years of the contract period."

Once a radiation-responsive biomarker is qualified, the development of a diagnostic test and the validation of a biomarker assay will fall under the Office of In Vitro Diagnostic Device and Safety for clearance or approval.

More information about the BARDA funding opportunity can be found here.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.